cancer screening

News

A recommendation on prostate cancer screening has been delivered in the UK, upsetting patient groups whilst being endorsed by medical organisations.

News

Data from a new phase 3 trial of Grail's blood test for multiple cancers show improved efficacy and a lower rate of false alarms than a prior study.

Oncology

The future of prostate cancer care lies in reimagining how we diagnose and monitor the disease.

News

An AI could help to detect aggressive interval breast cancers that are diagnosed in between routine screening appointments, say US researchers.

News

The NHS has started a pilot project that will sift through patient records to try to detect people at risk of pancreatic cancer.

News

Grail is eyeing FDA approval of its Galleri cancer screening blood test after a second positive phase 3 trial.